vs

Side-by-side financial comparison of IMMERSION CORP (IMMR) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

IMMERSION CORP is the larger business by last-quarter revenue ($372.9M vs $208.9M, roughly 1.8× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -4.6%, a 7.2% gap on every dollar of revenue. On growth, IMMERSION CORP posted the faster year-over-year revenue change (750.4% vs 27.1%). Over the past eight quarters, IMMERSION CORP's revenue compounded faster (537.9% CAGR vs 25.8%).

Immersion Corporation is an Aventura, Florida based developer and licensor of touch feedback technology, also known as haptic technology. Immersion Corporation has been accused of being a patent troll. Founded in 1993 by Louis Rosenberg, it is currently headed by lawyer Francis Jose, who serves as both chief executive officer and general counsel.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

IMMR vs IRTC — Head-to-Head

Bigger by revenue
IMMR
IMMR
1.8× larger
IMMR
$372.9M
$208.9M
IRTC
Growing faster (revenue YoY)
IMMR
IMMR
+723.3% gap
IMMR
750.4%
27.1%
IRTC
Higher net margin
IRTC
IRTC
7.2% more per $
IRTC
2.7%
-4.6%
IMMR
Faster 2-yr revenue CAGR
IMMR
IMMR
Annualised
IMMR
537.9%
25.8%
IRTC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMMR
IMMR
IRTC
IRTC
Revenue
$372.9M
$208.9M
Net Profit
$-17.0M
$5.6M
Gross Margin
70.9%
Operating Margin
-2.8%
1.1%
Net Margin
-4.6%
2.7%
Revenue YoY
750.4%
27.1%
Net Profit YoY
-191.3%
518.5%
EPS (diluted)
$-0.57
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMMR
IMMR
IRTC
IRTC
Q4 25
$208.9M
Q3 25
$192.9M
Q2 25
$372.9M
$186.7M
Q1 25
$471.3M
$158.7M
Q4 24
$616.2M
$164.3M
Q3 24
$147.5M
Q2 24
$95.5M
$148.0M
Q1 24
$43.8M
$131.9M
Net Profit
IMMR
IMMR
IRTC
IRTC
Q4 25
$5.6M
Q3 25
$-5.2M
Q2 25
$-17.0M
$-14.2M
Q1 25
$24.1M
$-30.7M
Q4 24
$30.8M
$-1.3M
Q3 24
$-46.2M
Q2 24
$26.4M
$-20.1M
Q1 24
$18.7M
$-45.7M
Gross Margin
IMMR
IMMR
IRTC
IRTC
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
IMMR
IMMR
IRTC
IRTC
Q4 25
1.1%
Q3 25
-4.4%
Q2 25
-2.8%
-10.0%
Q1 25
7.5%
-20.5%
Q4 24
11.4%
-2.5%
Q3 24
-34.1%
Q2 24
23.7%
-15.5%
Q1 24
37.9%
-28.9%
Net Margin
IMMR
IMMR
IRTC
IRTC
Q4 25
2.7%
Q3 25
-2.7%
Q2 25
-4.6%
-7.6%
Q1 25
5.1%
-19.3%
Q4 24
5.0%
-0.8%
Q3 24
-31.3%
Q2 24
27.7%
-13.6%
Q1 24
42.5%
-34.6%
EPS (diluted)
IMMR
IMMR
IRTC
IRTC
Q4 25
$0.18
Q3 25
$-0.16
Q2 25
$-0.57
$-0.44
Q1 25
$0.73
$-0.97
Q4 24
$0.93
$-0.03
Q3 24
$-1.48
Q2 24
$0.81
$-0.65
Q1 24
$0.59
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMMR
IMMR
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$161.4M
$583.8M
Total DebtLower is stronger
$103.1M
Stockholders' EquityBook value
$298.1M
$152.7M
Total Assets
$1.1B
$1.0B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMMR
IMMR
IRTC
IRTC
Q4 25
$583.8M
Q3 25
$565.2M
Q2 25
$161.4M
$545.5M
Q1 25
$153.9M
$520.6M
Q4 24
$159.3M
$535.6M
Q3 24
$522.0M
Q2 24
$133.4M
$561.5M
Q1 24
$179.1M
$569.1M
Total Debt
IMMR
IMMR
IRTC
IRTC
Q4 25
Q3 25
Q2 25
$103.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IMMR
IMMR
IRTC
IRTC
Q4 25
$152.7M
Q3 25
$121.9M
Q2 25
$298.1M
$103.7M
Q1 25
$317.9M
$86.7M
Q4 24
$305.5M
$90.9M
Q3 24
$71.8M
Q2 24
$273.4M
$99.2M
Q1 24
$201.5M
$90.3M
Total Assets
IMMR
IMMR
IRTC
IRTC
Q4 25
$1.0B
Q3 25
$995.2M
Q2 25
$1.1B
$964.0M
Q1 25
$1.4B
$926.1M
Q4 24
$1.4B
$931.4M
Q3 24
$909.7M
Q2 24
$1.2B
$919.2M
Q1 24
$244.7M
$909.8M
Debt / Equity
IMMR
IMMR
IRTC
IRTC
Q4 25
Q3 25
Q2 25
0.35×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMMR
IMMR
IRTC
IRTC
Operating Cash FlowLast quarter
$26.2M
Free Cash FlowOCF − Capex
$14.5M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMMR
IMMR
IRTC
IRTC
Q4 25
$26.2M
Q3 25
$34.9M
Q2 25
$27.7M
Q1 25
$-43.7M
$-7.9M
Q4 24
$19.2M
Q3 24
$24.3M
Q2 24
$-85.9M
$11.8M
Q1 24
$29.9M
$-52.0M
Free Cash Flow
IMMR
IMMR
IRTC
IRTC
Q4 25
$14.5M
Q3 25
$20.1M
Q2 25
$17.3M
Q1 25
$-46.2M
$-17.3M
Q4 24
$12.4M
Q3 24
$15.5M
Q2 24
$3.4M
Q1 24
$-61.8M
FCF Margin
IMMR
IMMR
IRTC
IRTC
Q4 25
6.9%
Q3 25
10.4%
Q2 25
9.3%
Q1 25
-9.8%
-10.9%
Q4 24
7.5%
Q3 24
10.5%
Q2 24
2.3%
Q1 24
-46.8%
Capex Intensity
IMMR
IMMR
IRTC
IRTC
Q4 25
5.6%
Q3 25
7.7%
Q2 25
5.6%
Q1 25
0.5%
5.9%
Q4 24
4.2%
Q3 24
6.0%
Q2 24
5.7%
Q1 24
7.4%
Cash Conversion
IMMR
IMMR
IRTC
IRTC
Q4 25
4.70×
Q3 25
Q2 25
Q1 25
-1.82×
Q4 24
Q3 24
Q2 24
-3.25×
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMMR
IMMR

Course Material Sale$150.9M40%
General Merchandise Sale$138.0M37%
Rental Services$51.8M14%
Services And Other Revenue$25.6M7%
Per Unit Royalties$1.8M0%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons